Question: Should COVID-19 patients with hypertension or heart disease be taken off their ACE-I or ARB medications?

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Hypertension
Are patients with hypertension at higher risk for severe illness from COVID-19?
section_content: Although many patients with severe illness from COVID-19 have underlying
hypertension, it is unclear at this time if hypertension is an independent
risk factor for severe illness from COVID-19. Hypertension is common in the
United States. Hypertension is more frequent with advancing age and among men,
non-Hispanic blacks, and people with other underlying medical conditions such
as obesity, diabetes, and serious heart disease. At this time, people whose
only underlying medical condition is hypertension are not considered to be at
higher risk for severe illness from COVID-19.

Reviewer feedback on this answer:
Answer only talks about hypertension and risk factors for COVID-19 for people who have hypertension and says nothing about medication changes.
The question is about whether people with hypertension should still use medication. This response is about their risk of getting the coronavirus.

Reviewer ratings:
Bad
Bad

Answer passage (source: CDC):
page_title: Frequently Asked Questions
section_headers: Higher Risk
Are there any medications I should avoid taking if I have COVID-19?
section_content: Currently, there is no evidence to show that taking ibuprofen or naproxen can
lead to a more severe infection of COVID-19.
People with high blood pressure should take their blood pressure medications,
as directed, and work with their healthcare provider to make sure that their
blood pressure is as well controlled as possible. Any changes to your
medications should only be made by your healthcare provider.

Reviewer feedback on this answer:
Answer does not relate to either hypertension or changing of ACE-I or ARB medications.
The question isn't about whether to take ibuprofen. It's not relevant at all.

Reviewer ratings:
Bad
Bad

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Hypertension
Should angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) be stopped in patients with COVID-19?
section_content: No. The American Heart Association, the Heart Failure Society of America, and
the American College of Cardiology recommendexternal
icon continuing ACE-I or ARB medications for all patients already
prescribed those medications for indications such as heart failure,
hypertension, or ischemic heart disease. At this time, available evidence
demonstrates no indication of COVID-specific harm from these agents. Several
randomized controlled trials are under way to better answer this important
clinical question. Cardiovascular disease patients diagnosed with COVID-19
should be fully evaluated by a healthcare professional before adding or
removing any treatments, and any changes to their treatment should be based on
the latest scientific evidence. Patients who rely on ACE-Is or ARBs to treat
chronic conditions and have additional questions should speak to their
healthcare provider for individualized management

Reviewer feedback on this answer:
Answer is given explicitly regarding ACE-I or ARB medications within the very first sentence and gives an explanation as to why answer was given.
They brought up what multiple organizations recommend regarding the medication.

Reviewer ratings:
Excellent
Excellent